摘要
该项目由世界500强企业——中国医药集团投资建设,总规划面积500亩,建筑面积40万平方米,投资20亿元,主要建设研发中心、生产车间和山东区企业总部。园区依托国药集团庞大的资源体系,集聚产业链上下游企业来坊发展。
Invested by Sinopharm Group.a Fortune Global 500 enterprise,Sinopharm(Weifang) Medical Sci-Tech Industrial Park has a total planned area of 500 mu.a floor area of 400,000 square meters and an investment of two billion yuan.It plans to build mainly the R&D center,production workshop and Shandong enterprise headquarters.Relying on the huge resource system of Sinopharm Group.the park will gather the upstream and downstream enterprises in the industrial chain to develop in Fangzi District.It will also construct a medical and health industrial system covering medical device manufacturing,the production and processing of Chinese patent medicine,the production of medical consumables,and the R&D of high and new technology to forge the first operation service brand in China’s medical sci-tech industrial parks.
出处
《走向世界》
2021年第39期58-58,共1页
Openings
